Deutsche Bank Raises Neurocrine Biosciences Price Target to $175
Deutsche Bank raised its price target to $175 from $165 and kept its Hold rating.
Related stories
Keurig Dr Pepper Shares Fall About 4% on Slower Coffee Growth
The company flagged slower-than-expected growth in its US coffee segment for Q4.
M impact | EQUITY | Nov 03, 2026, 02:37 PM UTC
Volaris Shares Rise 10% at the Open
M impact | EQUITY | Nov 03, 2026, 02:36 PM UTC
Upwork raises annual adjusted profit forecast; shares rise 2.7%
M impact | EQUITY | Nov 03, 2026, 02:36 PM UTC
Proto Labs Raises Multi Jet Fusion 3D Printing Capacity by 50%
Proto Labs said it raised its HP Multi Jet Fusion 3D-printing capacity by 50%.
M impact | EQUITY | Nov 03, 2026, 02:36 PM UTC
Volaris shares surge 10% after opening
M impact | EQUITY | Nov 03, 2026, 02:36 PM UTC
SBI shares fall 1.70% despite stronger Q2 performance
State Bank of India shares closed at Rs.970 after erasing intraday gains, despite September-quarter results coming in ahead of Street estimates.
M impact | EQUITY | Nov 03, 2026, 02:35 PM UTC